Market Cap

Valneva SE Market Capitalization:

€655.1 Million

EUR as of Jan. 1, 2026

US$769.4 Million

business Valneva SE Company Profile

Valneva SE Main Stock Listing

Euronext: VLA

Market Capitalization History of Valneva SE

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Valneva SE market cap

Date Market Cap YoY Change
Jan. 1, 2026 €655.1 M 84.37%
Jan. 1, 2025 €355.3 M -47.34%
Jan. 1, 2024 €674.8 M -28.21%
Jan. 1, 2023 €939.9 M -52.88%
Jan. 1, 2022 €1.99 B 61.18%
Jan. 1, 2021 €1.24 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Valneva SE Categories

France languages Healthcare languages Biotechnology
France Healthcare France Biotechnology

Stocks & Indices

Valneva SE has the following listings and related stock indices.


Stock: Euronext: VLA

Stock: FSX: AYJ

Stock: NASDAQ: VALN

Stock: OTC: INRLF

Stock: OTC: VNVLF

Stock: XSTU: VLA

Stock: FSX: AYJ0

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.